| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2897512 | Cardiocore | 2013 | 6 Pages |
Abstract
Brugada syndrome is still one of the most important channelopathies studied in the major experimental laboratories with the aim of finding a drug capable of eliminating secondary damages. The current indications for genetic testing, the limitations of provocative drug challenge testing, and intracardiac electrophysiology study and the therapeutics possibilities are reviewed in detail.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
RocÃo Picón Heras,